IDEAYA Biosciences, Inc. (IDYA) Financial Statements (2024 and earlier)

Company Profile

Business Address 7000 SHORELINE COURT, SUITE 350
SOUTH SAN FRANCISCO, CA 94080
State of Incorp. DE
Fiscal Year End December 31
Industry (SIC) 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in thousands)

9/30/2023
MRQ
12/31/2022
12/31/2021
12/31/2020
12/31/2019
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments364,829246,770283,58598,956
Cash and cash equivalents68,63292,04672,03734,067
Short-term investments296,197154,724211,54864,889
Receivables2111,1031,877 
Other undisclosed current assets5,4143,1233,1432,698
Total current assets:370,454250,996288,605101,654
Noncurrent Assets
Operating lease, right-of-use asset2,4843,8985,2055,057
Property, plant and equipment6,5094,7634,2714,642
Long-term investments and receivables8,317121,293 1,526
Long-term investments8,317121,293 1,526
Restricted cash and investments106106106106
Other noncurrent assets992918216
Total noncurrent assets:17,515130,3519,66411,347
TOTAL ASSETS:387,969381,347298,269113,001
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities21,27914,4209,4695,732
Accounts payable4,2802,100953709
Accrued liabilities16,99912,3208,5165,023
Deferred revenue8,56829,04027,613 
Debt    1,145
Other liabilities   1863
Other undisclosed current liabilities1,8711,6991,540 
Total current liabilities:31,71845,15938,6406,940
Noncurrent Liabilities
Long-term debt and lease obligation:  3,4825,1835,627
Liabilities, other than long-term debt 6,79631,19256,17234
Deferred revenue 5,18531,19256,160 
Other liabilities   1234
Operating lease, liability 1,6113,4825,1835,627
Total noncurrent liabilities: 6,79634,67461,3555,661
Total liabilities:38,51479,83399,99512,601
Equity
Equity, attributable to parent349,455301,514198,274100,400
Common stock5432
Additional paid in capital587,724478,970325,250192,824
Accumulated other comprehensive income (loss)(2,871)(712)765
Accumulated deficit(235,403)(176,748)(126,986)(92,491)
Total equity:349,455301,514198,274100,400
TOTAL LIABILITIES AND EQUITY:387,969381,347298,269113,001

Income Statement (P&L) ($ in thousands)

9/30/2023
TTM
12/31/2022
12/31/2021
12/31/2020
12/31/2019
Revenues50,93127,94119,538 
Gross profit:50,93127,94119,538 
Operating expenses(113,433)(78,209)(54,882)(44,271)
Operating loss:(62,502)(50,268)(35,344)(44,271)
Nonoperating income3,8475068492,296
Investment income, nonoperating    2,288
Loss from continuing operations:(58,655)(49,762)(34,495)(41,975)
Loss before gain (loss) on sale of properties:(49,762)(34,495)(41,975)
Net loss available to common stockholders, diluted:(58,655)(49,762)(34,495)(41,975)

Comprehensive Income ($ in thousands)

9/30/2023
TTM
12/31/2022
12/31/2021
12/31/2020
12/31/2019
Net loss:(58,655)(49,762)(34,495)(41,975)
Comprehensive loss:(58,655)(49,762)(34,495)(41,975)
Other undisclosed comprehensive income (loss), net of tax, attributable to parent(2,159)(719)(58)96
Comprehensive loss, net of tax, attributable to parent:(60,814)(50,481)(34,553)(41,879)

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: